Table 2.

Direct medical costs for annual treatment of SCD

Items	Setting	Costs (USD)
Medication and monitoring tests	Low-dose Crizanlizumab	13,393
	High-dose Crizanlizumab	6,696
	Hydroxyurea	118.38
Hospitalization per pain crisis episode		44.36
IV administration services	Crizanlizumab	39.92